Hedge fund ValueAct Capital LLC said it had taken a $1 billion stake in Rupert Murdoch-controlled film and TV company Twenty-First Century Fox Inc
Fox withdrew its $80 billion bid to buy Time Warner Inc last week after being rebuffed by the owner of CNN, HBO and Warner Bros studios. Murdoch said he has no plans to pursue another company as an alternative, Reuters reported.
U.S. private equity fund Francisco Partners is in talks to buy a controlling stake in Israeli software firm Sapiens (SPNS.O), a deal that would value the company at more than $450 million, Israeli media reported on Tuesday.
Carlyle has made an undisclosed investment in Ganji.com. Based in Beijing, China, Ganji.com is an operator of online and mobile-based classifieds.
The family owner of German fashion group Bogner has appointed Goldman Sachs to find a buyer for the maker of upmarket winter jackets and skiwear, sources told Reuters.
Apax Partners is buying Answers Corp., parent of Answers.com, from Summit Partners and TA Associates.
JPMorgan Chase’s private equity investment group One Equity Partners has finally found a path to spinning out on its own.
Maxim Partners and Falcon Investment Advisors have acquired Laney Directional Drilling Co., a horizontal drilling company for the oil and gas pipeline industry. Laney was previously owned by Chart Capital Partners, Prudential Capital Partners, Quilvest USA and Basic Materials and Services.
Graycliff Partners has completed an investment in Fairway Building Products. Graycliff invested subordinated debt and equity financing in support of the acquisition of a controlling stake in Fairway Building Products by Argosy Private Equity. This was the fifth investment from the Graycliff Mezzanine II LP, a fund with more than $250 million in commitments.
H.I.G. Growth Partners has invested in LuLu's Fashion Lounge, an e-commerce retailer of young women's apparel, shoes and accessories. H.I.G. partnered with LuLu's owners Colleen Winter and Debra Cannon on the transaction. John Kim and Evan Karp from H.I.G. will join LuLu's board of directors as part of the deal.
DRI Capital has acquired royalties relating to sales of a certain drug from Rush University Medical Center for about $42 million. The drug, Ampyra, is FDA-approved medication to improve walking in people with multiple sclerosis. DRI Capital is making the investment from its Drug Royalty III, which closed on $1.4 billion in September.